Dataset Information


GM-CSF promotes the immunosuppressive activity of glioma-infiltrating myeloid cells through interleukin-4 receptor-?.

ABSTRACT: Malignant gliomas are lethal cancers in the brain and heavily infiltrated by myeloid cells. Interleukin-4 receptor-? (IL-4R?) mediates the immunosuppressive functions of myeloid cells, and polymorphisms in the IL-4R? gene are associated with altered glioma risk and prognosis. In this study, we sought to evaluate a hypothesized causal role for IL-4R? and myeloid suppressor cells in glioma development. In both mouse de novo gliomas and human glioblastoma cases, IL-4R? was upregulated on glioma-infiltrating myeloid cells but not in the periphery or in normal brain. Mice genetically deficient for IL-4R? exhibited a slower growth of glioma associated with reduced production in the glioma microenvironment of arginase, a marker of myeloid suppressor cells, which is critical for their T-cell inhibitory function. Supporting this result, investigations using bone marrow-derived myeloid cells showed that IL-4R? mediates IL-13-induced production of arginase. Furthermore, glioma-derived myeloid cells suppressed T-cell proliferation in an IL-4R?-dependent manner, consistent with their identification as myeloid-derived suppressor cells (MDSC). Granulocyte macrophage colony-stimulating factor (GM-CSF) plays a central role for the induction of IL-4R? expression on myeloid cells, and we found that GM-CSF is upregulated in both human and mouse glioma microenvironments compared with normal brain or peripheral blood samples. Together, our findings establish a GM-CSF-induced mechanism of immunosuppression in the glioma microenvironment via upregulation of IL-4R? on MDSCs.

SUBMITTER: Kohanbash G 

PROVIDER: S-EPMC3829000 | BioStudies | 2013-01-01

REPOSITORIES: biostudies

Similar Datasets

2018-01-01 | S-EPMC5997508 | BioStudies
1000-01-01 | S-EPMC5737598 | BioStudies
2019-01-01 | S-EPMC6399310 | BioStudies
1000-01-01 | S-EPMC3031417 | BioStudies
2017-09-11 | GSE83458 | GEO
1000-01-01 | S-EPMC4998996 | BioStudies
2019-01-01 | S-EPMC6431635 | BioStudies
2020-01-01 | S-EPMC7378736 | BioStudies
2016-01-01 | S-EPMC5371700 | BioStudies
1000-01-01 | S-EPMC6116484 | BioStudies